Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 3 (PPIAP3) is a pseudogene located in the human genome that shares high sequence similarity with the functional PPIA gene but is incapable of producing a functional protein. By definition, pseudogenes are typically the result of gene duplication or retrotransposition events leading to inactivation through mutations such as premature stop codons or frameshifts. While pseudogenes can sometimes be transcribed and influence gene regulation (for example, by acting as miRNA sponges or sources of regulatory RNAs), there is no evidence that PPIAP3 plays a direct biological or disease role or is targeted by drugs. Pseudogenes, including PPIAP3, are often sources of confusion in genetic and molecular studies due to their high homology with functional genes, potentially complicating gene amplification and detection[1][7][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 3 (PPIAP3).